Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Division of Cancer Prevention Staff

Portrait of Mark E. Sherman, MD

Mark E. Sherman, MD

Chief
Breast and Gynecologic Cancer Research Group
Location
Division of Cancer Prevention
National Cancer Institute
9609 Medical Center Drive, 5E334
Rockville, MD 20850
Phone (240) 276-7051
Fax (240) 276-7828
E-mail shermanm@exchange.nih.gov
  • Dr. Mark Sherman graduated from the University of Chicago Pritzker School of Medicine in 1983 and completed a pathology residency at the New England Deaconess Hospital and a cytopathology fellowship at Montefiore Medical Center. His interests include the risk assessment, screening, biomarker development and validation, and prevention of gynecological and breast cancers. Dr. Sherman has broad experience in molecular epidemiology and clinical research, including lead participation in observational studies, clinical trials and investigations designed to secure FDA approvals for new devices. He has authored over 350 manuscripts and lectured throughout the U.S. and internationally on a range of topics and serves on multiple journal editorial boards, including the Journal of the National Cancer Institute.

    Dr. Sherman serves on the Steering Committee of the American Association for Cancer Research Molecular Epidemiology Working Group, the Biospecimen Advisory Group of the American Cancer Society, the Avon Foundation for Women, and the Scientific Advisory Board for a multi-center DOD-funded award related to ovarian cancer led by researchers at Johns Hopkins. He has received NIH Merit Awards, the Exemplary Service Award from the NCI Division of Cancer Epidemiology and Genetics, NCI Technology Transfer and Performance Awards, and the United States and Canadian Academy of Pathology Service Award. He is a co-author of the Armed Forces Institute of Pathology fascicle on Tumors of the Cervix, Vagina and Vulva, and contributed to the revised World Health Organization monograph on the pathology and genetics of gynecologic tumors and breast cancer.

  • Molecular epidemiology and biomarker research related to gynecological tumors and breast cancer

  • Cancer screening for and prevention of breast and gynecological cancers

  • Application of molecular pathology in epidemiological research
  • Board certified in anatomic and clinical pathology with added qualification in cytopathology

  • Experience in designing and conducting large epidemiological studies to understand cancer etiology and pathogenesis, identification of biomarkers, screening and prevention

  • Cancer screening for and prevention of breast and gynecological cancers



Back to top